OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
23
Results
Show all
Save search
Copy query
Show results for
Unknown
(23)
Publication Date
Release Date
2021
(8)
2023
(5)
2025
(4)
2022
(2)
2026
(1)
2024
(1)
2020
(1)
2015
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
A Case of Severe Combined Immunodeficiency Missed by Newborn Screening.
Not available
S-EPMC7954206
|
biostudies-literature
Cite
Targeted deep sequencing identifies mosaicism in patients with immune dysregulation.
Not available
S-EPMC12916128
|
biostudies-literature
Cite
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials.
Not available
S-EPMC4561451
|
biostudies-literature
Cite
Autoantibodies against type I IFNs in patients with critical influenza pneumonia.
Not available
S-EPMC9485705
|
biostudies-literature
Cite
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Not available
S-EPMC10074346
|
biostudies-literature
Cite
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
Not available
S-EPMC8362592
|
biostudies-literature
Cite
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.
Not available
S-EPMC8532080
|
biostudies-literature
Cite
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Not available
S-EPMC7857407
|
biostudies-literature
Cite
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
Not available
S-EPMC7953461
|
biostudies-literature
Cite
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Not available
S-EPMC10208981
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets